Activation of the EGFR in epithelial cells and their derived tumours including SCC is stimulated by ligand binding that is required to activate its downstream signaling targets that mediate its effects on growth, metabolic activity and cell survival [9], [10], [21]. This evidence concerns the gene EGFR and neoplasm.